Humira® (adalimumab) Pen – Rough Retail Cost (U.S.) | Pen Size | Typical Retail Price (without insurance) | |----------|------------------------------------------| | 40 mg | ≈ $3,600 – $4,200 per month (about $90–$105 per dose) | | 80 mg | ≈ $7,200 – $8,400 per month (about $180–$210 per dose) | These figures are approximate retail prices for a 40‑mg or 80‑mg Humira pen. The actual out‑of‑pocket cost can be much lower if you have insurance, a patient assistance program, or a discount card. Prices also vary by pharmacy, geographic region, and any negotiated rebates. How to get a more accurate estimate Check with your pharmacy – most pharmacies can give you a “list price” and also let you see how much your insurance will cover. Contact your insurer – they can confirm the formulary tier, prior‑auth requirements, and any copayment assistance. Use online tools – websites such as GoodRx or the Humira® patient assistance program can provide up‑to‑date pricing and discount information. If you’re looking for exact numbers for your specific situation (e.g., Medicare Part D plan, Medicaid, or a private insurance plan), the quickest route is to call your pharmacist or insurance provider.

Ask Questions, Get Industry Insights … Instantly

Save time and get answers to complex questions with AI chat

Recent Questions

Are there income restrictions for lipitor's patient program?
Pramlintide acetate price?
Complera manufacturer?
Is januvia still on the market?
Zemdri nce gain exclusivity 2028 patent 2031?

Humira pen price?

See the DrugPatentWatch profile for Humira

Humira® (adalimumab) Pen – Rough Retail Cost (U.S.)

| Pen Size | Typical Retail Price (without insurance) |
|----------|------------------------------------------|
| 40 mg | ≈ $3,600 – $4,200 per month (about $90–$105 per dose) |
| 80 mg | ≈ $7,200 – $8,400 per month (about $180–$210 per dose) |

These figures are approximate retail prices for a 40‑mg or 80‑mg Humira pen. The actual out‑of‑pocket cost can be much lower if you have insurance, a patient assistance program, or a discount card. Prices also vary by pharmacy, geographic region, and any negotiated rebates.

How to get a more accurate estimate

Check with your pharmacy – most pharmacies can give you a “list price” and also let you see how much your insurance will cover.
Contact your insurer – they can confirm the formulary tier, prior‑auth requirements, and any copayment assistance.
Use online tools – websites such as GoodRx or the Humira® patient assistance program can provide up‑to‑date pricing and discount information.

If you’re looking for exact numbers for your specific situation (e.g., Medicare Part D plan, Medicaid, or a private insurance plan), the quickest route is to call your pharmacist or insurance provider.

AI-Drug Label Prescribing Information Alignment Report

100

100%

Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The only evaluated claims concern retail pricing, which is absent from the supplied FDA-approved prescribing information. Therefore, there is no on-label content to confirm or contradict; the claims are simply unsupported by the label.

Category Scores

Accurate Statements

Unsupported Statements

Humira (adalimumab) 40 mg pen has a typical approximate U.S. retail price of about $3,600–$4,200 per month (about $90–$105 per dose) without insurance.

Retail pricing/cost-per-dose estimates are absent from the FDA-approved prescribing information.

Humira (adalimumab) 80 mg pen has a typical approximate U.S. retail price of about $7,200–$8,400 per month (about $180–$210 per dose) without insurance.

Retail pricing/cost-per-dose estimates are absent from the FDA-approved prescribing information.

Contradictions

Important Omissions

Any FDA-label-supported information relevant to Humira dosing, administration, contraindications, warnings/precautions, interactions, or adverse reactions (none were provided in the claims).

Importance: Low

Safety Assessment

Potential Patient Risk: Low

The claims are financial (retail pricing) and do not directly affect dosing, contraindications, or safety information described in the label. They remain unsupported by labeling.

Regulatory Assessment

On Label	No
Off-label Discussion	No
Promotes Unapproved Use	No
Hallucination Risk	Low

Recommendation

Mostly Aligned

Primary Issue
Pricing/cost-per-dose assertions are not supported by FDA-approved Humira prescribing information.

Suggested Improvement
Remove or replace the retail pricing estimates with information that is supported by the provided label or clearly label the content as non-prescribing-information (non-label) data.

Drug Brand Mention Assessment

Branding Score

Visibility

Mentioned

Ranking

Sentiment

Recommendation Status

mentioned only

Brand Perception

Best Known For

Rough Retail Cost (U.S.)

Core Claims

Gives rough retail cost for Humira pens (U.S.)
Approximate $3,600–$4,200 per month for 40mg pen (about $90–$105 per dose)
Approximate $7,200–$8,400 per month for 80mg pen (about $180–$210 per dose)
Actual out-of-pocket cost can be much lower with insurance, patient assistance, or a discount card
Prices vary by pharmacy, geographic region, and negotiated rebates

Differentiators

Breaks pricing out by 40mg vs 80mg pen sizes
Notes pricing is approximate and out-of-pocket may be much lower with insurance or assistance
Provides per-month and per-dose estimates

Pricing Perception: Premium